We seek highly innovative products, that are already approved, or that are in advanced stages of development, to in-license and commercialize in all or part of the territories covered by Medison.
/ Approach /
BRINGING ACCESS TO THE TABLE
Our holistic exposure to stakeholders across the spectrum is made possible through both eye-level relationships and an unprecedented access to Medison’s network. We fully immerse ourselves in the world of healthcare. We walk the hallways of academia and medical centers, listen to patients, engage with our global pharma partners, and meet with key opinion leaders.
With a rounded, patient-centric, industry-informed perspective, we search for and evaluate breakthrough technologies across various stages of development, prior to constructing an independent notion of both the problems being solved and the proposed solutions. Having assessed the industry’s willingness to adopt specific innovative solutions, we leverage strategic alliances and our investment vehicles to inject value into these innovative projects.
We view ourselves as ‘external R&D’ for Medison’s global partners. Each year hundreds of projects are funneled into Medison Ventures via our team and global network. Our continuous research and evaluation is informed by a deep understanding and appreciation of each partners’ specific needs, allowing us to find tailored opportunities to further drive their pipeline needs and long-term vision.
Investing in innovative therapies and digital health through various investment platforms backed by Medison and its partners.